Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

A critique of the second consensus criteria for multiple system atrophy.

Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Höglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK; Movement Disorder Society Multiple System Atrophy Study Group.

Mov Disord. 2019 Jul;34(7):975-984. doi: 10.1002/mds.27701. Epub 2019 Apr 29. No abstract available.

PMID:
31034671
2.

Factors to improve the interobserver agreement for gastric atrophy and intestinal metaplasia: consensus of definition and criteria.

Kim SS, Kook MC, Shin OR, Kim HS, Bae HI, Seo AN, Park DY, Choi IJ, Kim YI, Nam BH, Kim S.

Histopathology. 2018 Apr;72(5):838-845. doi: 10.1111/his.13442. Epub 2018 Jan 19.

PMID:
29161756
3.

Second consensus statement on the diagnosis of multiple system atrophy.

Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Dürr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M.

Neurology. 2008 Aug 26;71(9):670-6. doi: 10.1212/01.wnl.0000324625.00404.15.

4.

A validation exercise on the new consensus criteria for multiple system atrophy.

Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP.

Mov Disord. 2009 Nov 15;24(15):2272-6. doi: 10.1002/mds.22826.

PMID:
19845011
5.

Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.

Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Danis RP, Fleckenstein M, Freund KB, Grunwald J, Hoyng CB, Jaffe GJ, Liakopoulos S, Monés JM, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Staurenghi G.

Ophthalmology. 2018 Apr;125(4):537-548. doi: 10.1016/j.ophtha.2017.09.028. Epub 2017 Nov 2. Erratum in: Ophthalmology. 2019 Jan;126(1):177.

PMID:
29103793
6.

[Consensus on the diagnosis of multi-system atrophy].

Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G.

Neurologia. 1999 Nov;14(9):425-8. Review. Spanish.

PMID:
10613015
7.

A regional consensus recommendation on brain atrophy as an outcome measure in multiple sclerosis.

Alroughani R, Deleu D, El Salem K, Al-Hashel J, Alexander KJ, Abdelrazek MA, Aljishi A, Alkhaboori J, Al Azri F, Al Zadjali N, Hbahbih M, Sokrab TE, Said M, Rovira À.

BMC Neurol. 2016 Nov 24;16(1):240.

8.

Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group.

Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown RG, Burn DJ, Holton JL, Kaufmann H, Kostic VS, Ling H, Meissner WG, Poewe W, Semnic M, Seppi K, Takeda A, Weintraub D, Wenning GK; Movement Disorders Society MSA (MODIMSA) Study Group.

Mov Disord. 2014 Jun;29(7):857-67. doi: 10.1002/mds.25880. Epub 2014 Apr 18. Review.

9.

[Changes in clinical diagnostic criteria for multiple system atrophy].

Tison F.

Rev Neurol (Paris). 2000 Sep;156(8-9):711-7. Review. French.

PMID:
10992115
10.

Multiple system atrophy: the putative causative role of environmental toxins.

Hanna PA, Jankovic J, Kirkpatrick JB.

Arch Neurol. 1999 Jan;56(1):90-4. Review.

PMID:
9923766
11.

Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines.

Colosimo C, Vanacore N, Bonifati V, Fabbrini G, Rum A, De Michele G, De Mari M, Bonuccelli U, Nicholl DJ, Meco G; European Study Group on Atypical Parkinsonism (ESGAP) Consortium.

Acta Neurol Scand. 2001 Apr;103(4):261-4. No abstract available.

PMID:
11328200
12.

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.

Schenck CH, Montplaisir JY, Frauscher B, Hogl B, Gagnon JF, Postuma R, Sonka K, Jennum P, Partinen M, Arnulf I, Cochen de Cock V, Dauvilliers Y, Luppi PH, Heidbreder A, Mayer G, Sixel-Döring F, Trenkwalder C, Unger M, Young P, Wing YK, Ferini-Strambi L, Ferri R, Plazzi G, Zucconi M, Inoue Y, Iranzo A, Santamaria J, Bassetti C, Möller JC, Boeve BF, Lai YY, Pavlova M, Saper C, Schmidt P, Siegel JM, Singer C, St Louis E, Videnovic A, Oertel W.

Sleep Med. 2013 Aug;14(8):795-806. doi: 10.1016/j.sleep.2013.02.016. Epub 2013 Jul 22. Erratum in: Sleep Med. 2014 Jan;15(1):157.

PMID:
23886593
13.

Consensus statement on the diagnosis of multiple system atrophy.

Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK.

J Auton Nerv Syst. 1998 Dec 11;74(2-3):189-92. Review.

PMID:
9915636
14.

Consensus statement on the diagnosis of multiple system atrophy.

Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK.

J Neurol Sci. 1999 Feb 1;163(1):94-8. Review.

PMID:
10223419
15.

Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia.

Auzou N, Dujardin K, Biundo R, Foubert-Samier A, Barth C, Duval F, Tison F, Defebvre L, Antonini A, Meissner WG.

Parkinsonism Relat Disord. 2015 Oct;21(10):1273-7. doi: 10.1016/j.parkreldis.2015.08.013. Epub 2015 Aug 14.

PMID:
26305998
16.

[Multiple system atrophy].

Damon-Perrière N, Tison F, Meissner WG.

Psychol Neuropsychiatr Vieil. 2010 Sep;8(3):179-91. doi: 10.1684/pnv.2010.0212. Review. French.

17.

Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?

Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ, Quinn N.

Neurology. 2002 Nov 26;59(10):1486-91.

PMID:
12455559
18.

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.

Levin J, Maaß S, Schuberth M, Giese A, Oertel WH, Poewe W, Trenkwalder C, Wenning GK, Mansmann U, Südmeyer M, Eggert K, Mollenhauer B, Lipp A, Löhle M, Classen J, Münchau A, Kassubek J, Gandor F, Berg D, Egert-Schwender S, Eberhardt C, Paul F, Bötzel K, Ertl-Wagner B, Huppertz HJ, Ricard I, Höglinger GU; PROMESA Study Group.

Lancet Neurol. 2019 Aug;18(8):724-735. doi: 10.1016/S1474-4422(19)30141-3. Epub 2019 Jul 2.

PMID:
31278067
19.

Gastric precancerous lesions: heading for an international consensus.

Genta RM, Rugge M.

Gut. 1999 Jul;45 Suppl 1:I5-8. Review.

20.

Differentiation of Parkinsonism-Predominant Multiple System Atrophy from Idiopathic Parkinson Disease Using 3T Susceptibility-Weighted MR Imaging, Focusing on Putaminal Change and Lesion Asymmetry.

Hwang I, Sohn CH, Kang KM, Jeon BS, Kim HJ, Choi SH, Yun TJ, Kim JH.

AJNR Am J Neuroradiol. 2015 Dec;36(12):2227-34. doi: 10.3174/ajnr.A4442. Epub 2015 Sep 3.

Supplemental Content

Support Center